Linezolid for multidrug-resistant tuberculosis reply

被引：3
|
作者：
Chang, Kwok-Chiu [1 ]
Leung, Chi-Chiu [1 ]
Daley, Charles L. [2 ]
机构：
[1] Dept Hlth, TB & Chest Serv, Hong Kong, Hong Kong, Peoples R China
[2] Natl Jewish Hlth, Div Mycobacterial & Resp Infect, Denver, CO USA
来源：
LANCET INFECTIOUS DISEASES | 2013年 / 13卷 / 01期
关键词：
DRUG;
D O I：
10.1016/S1473-3099(12)70272-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [21] Multidrug-resistant tuberculosis in children: A practical update on epidemiology, diagnosis, treatment and prevention
    Gaensbauer, James T.
    Dash, Nabaneeta
    Verma, Sanjay
    Hall, Dj
    Adler-Shohet, Felice C.
    Li, Guyu
    Lee, Grace
    Dinnes, Laura
    Wendorf, Kristen
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 36
  • [22] Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis
    Chang, Kwok-Chiu
    Leung, Chi-Chiu
    Yew, Wing-Wai
    Leung, Eric Chung-Ching
    Leung, Wai-Man
    Tam, Cheuk-Ming
    Zhang, Ying
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5465 - 5475
  • [23] Evaluating the Efficacy of Capreomycin and Levofloxacin Combination Therapy in Multidrug-Resistant Tuberculosis Patients
    Xu, Sheng
    Ding, Guozheng
    APMIS, 2025, 133 (03)
  • [24] Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea
    Kim, Cheon Tae
    Kim, Tae-Ok
    Shin, Hong-Joon
    Ko, Young Chun
    Choe, Yeong Hun
    Kim, Hak-Ryul
    Kwon, Yong-Soo
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)
  • [25] Cost-effectiveness of Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the Republic of Korea
    Park, Hae-Young
    Ku, Hye-min
    Sohn, Hyun-Soon
    Seo, Hae-Sook
    Lee, Hyun Yung
    Lim, Kyung Hwa
    Kwon, Jin-Won
    CLINICAL THERAPEUTICS, 2016, 38 (03) : 655 - 667
  • [26] Improved outcomes following addition of bedaquiline and clofazimine to a treatment regimen for multidrug-resistant tuberculosis
    Yao, Ge
    Zhu, Muxin
    Nie, Qi
    Chen, Nanshan
    Tu, Shengjin
    Zhou, Yong
    Xiao, Fan
    Liu, Yuan
    Li, Xi
    Chen, Hua
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (01)
  • [27] Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
    Gausi, Kamunkhwala
    Chirehwa, Maxwell
    Ignatius, Elisa H.
    Court, Richard
    Sun, Xin
    Moran, Laura
    Hafner, Richard
    Wiesner, Lubbe
    Rosenkranz, Susan L.
    de Jager, Veronique
    de Vries, Nihal
    Harding, Joseph
    Gumbo, Tawanda
    Swindells, Susan
    Diacon, Andreas
    Dooley, Kelly E.
    McIlleron, Helen
    Denti, Paolo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (09) : 2489 - 2499
  • [28] Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China
    Zou, Jin
    Chen, Shuyan
    Rao, Weiqiao
    Fu, Liang
    Zhang, Jiancong
    Liao, Yunli
    Zhang, Ying
    Lv, Ning
    Deng, Guofang
    Yang, Shijin
    Lin, Liang
    Li, Lujin
    Liu, Siqi
    Qu, Jiuxin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (10)
  • [29] Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients
    Shao, Ge
    Bao, Ziwei
    Davies Forsman, Lina
    Paues, Jakob
    Werngren, Jim
    Niward, Katarina
    Schon, Thomas
    Bruchfeld, Judith
    Alffenaar, Jan-Willem
    Hu, Yi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Genetic characterization of N-acetyltransferase 2 variants in acquired multidrug-resistant tuberculosis in Indonesia
    Yuliwulandari, Rika
    Prayuni, Kinasih
    Razari, Intan
    Susilowati, Retno W.
    Zulhamidah, Yenni
    Soedarsono, Soedarsono
    Sofro, Abdul Salam M.
    Tokunaga, Katsushi
    PHARMACOGENOMICS, 2021, 22 (03) : 157 - 163
12345